368.82USD-0.09%Mkt Cap: 41.76B $P/E: 66.161d ago
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products incl…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
$12.48BUSD
Key Statistics
Company
Market Cap41.76B $
Enterprise Value38.93B $
Revenue (TTM)6.13B $
Gross Profit4.67B $
Net Income (TTM)286.93M $
Revenue/Share55.27 USD
Last Price368.82 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12.0K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)66.16
P/E (Forward)35.90
PEG—
EV/EBITDA36.33
EV/Revenue6.35
P/S6.81
P/B8.06
EPS (TTM)5.46
EPS (Forward)10.28
52W Range
354.3158% of range379.17
52W High379.17 USD
52W Low354.31 USD
Profitability
Gross Margin87.49%
Oper. Margin19.06%
EBITDA Margin17.48%
Profit Margin5.37%
ROE6.58%
ROA3.50%
Growth
Revenue Growth29.60%
Earnings Growth166.70%
Cash Flow & Leverage
Operating CF1.13B $
CapEx (TTM)266.53M $
FCF Margin14.34%
FCF Yield2.10%
Net Debt-3.05B $
Net Debt/EBITDA-2.84
Balance Sheet
Debt/Equity0.25
Current Ratio3.40
Quick Ratio2.91
Book Value/Sh45.78 USD
Cash/Share44.84 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)433.02 USD
Upside (mean)+17.4%
Target Range370.00 USD – 528.00 USD
$370.00+17.4% to mean$528.00
# Analysts27
Ownership
Shares Out.104.27M
Float80.95M
Insiders17.28%
Institutions33.13%
Short Interest
Short Ratio2.4d
Short % Float1.09%
Short % Out.0.77%
Shares Short880.63K
Short (prev mo.)791.58K
Technical
SMA 50311.89 (+18.3%)
SMA 200316.49 (+16.5%)
Beta0.50
S&P 52W Chg18.16%
Avg Vol (30d)357.59K
Avg Vol (10d)493.00K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—